Inflammatory Bowel Disease

In an exclusive video with Healio Gastroenterology, Loren Laine, MD, FACG, chair of the Digestive Disease Week counsel, Yale School of Medicine, highlighted a few presentations from Digestive Disease Week.

Among young patients with inflammatory bowel disease, most whom were positive for SARs-CoV-2, had a non-neutralizing antibody, according to data presented at Digestive Disease Week.

Crohn’s disease previously unresponsive to conventional and biologic therapies showed response to Skyrizi, achieving clinical remission in more than a third of patients regardless of dosing, according to a presentation at Digestive Diseases Week.

Increased consumption of processed foods correlated with the development of inflammatory bowel disease, according to a presentation at Digestive Disease Week.

In this video exclusive, Benjamin Click, MD, from Cleveland Clinic, discussed the accuracy of imaging for the detection of postoperative Crohn’s disease recurrence.

Influenza vaccination rates were lower among Black patients with inflammatory bowel disease vs. white patients with IBD, according to research presented at Digestive Disease Week.

Alcohol use disorder correlated with a higher risk for in-hospital mortality among patients with inflammatory bowel disease, according to a presentation at Digestive Disease Week.

Crohn’s disease and ulcerative colitis disproportionately affected non-Hispanic white patients, according to research presented at Digestive Disease Week.

In this video exclusive, Miguel Regueiro, MD, discussed a presentation from Digestive Disease Week on the impact of biologics on the prevalence of osteoporosis and bone fractures in patients with inflammatory bowel disease.

Patients with major depressive disorder and inflammatory bowel disease had increased morbidity and discharge rates to non-home settings as well as increased heathcare burden, according to research presented at Digestive Disease Week.